What did @stedtalks actually say?
The creator says they've been injecting BPC-157 subcutaneously every day for three to four weeks to recover from a shoulder injury. Their claim is direct: BPC-157 is "great for inflammation and regeneration of any damage to the tendons and ligaments" and has been "very, very helpful" for their recovery. That's two claims bundled into one video: a biological mechanism claim and a personal outcomes claim. We should treat them separately, because they deserve different levels of scrutiny.
The administration method they show, drawing from a vial and injecting subcutaneously near the injured site, is consistent with how BPC-157 is typically used in the research and bodybuilding communities. They mention cleaning the area first, which is basic harm reduction. No dose is stated, which is honestly a relief given how loose peptide dosing advice gets on TikTok.
Does the science back this up?
Partially, but with a significant asterisk: nearly all the compelling data comes from animal studies. The human trial record is thin to nonexistent for injury-specific indications.
BPC-157, short for Body Protection Compound 157, is a synthetic pentadecapeptide derived from a protein found in gastric juice. Preclinical research is genuinely interesting. Sikiric et al. (2018, Current Pharmaceutical Design) documented tendon-to-bone healing acceleration in rat models, including upregulation of growth hormone receptors. Pevec et al. (2010, Journal of Orthopaedic Research) showed improved collagen organization in Achilles tendon injuries in rats treated with BPC-157. The anti-inflammatory signaling, particularly around nitric oxide pathways and VEGF-mediated angiogenesis, has been replicated across multiple animal studies.
The problem is the translational leap. Animal tendons are not human shoulders. There are no published randomized controlled trials in humans for musculoskeletal injury recovery using BPC-157. The FDA has not approved it for any indication, and the compound remains on the FDA's list of substances that cannot be compounded by 503A pharmacies for humans. The creator's confidence that it's "great" for tendon and ligament regeneration is running well ahead of the human evidence.
What did they get wrong (or right)?
They got the mechanism directionally right. BPC-157 does appear to promote tendon and ligament healing in preclinical models, and the anti-inflammatory signaling is well-documented in animal literature. Calling it "great for inflammation" is a reasonable shorthand for what the rodent data suggests. Credit where it's due.
What they got wrong is the certainty. Saying something is "great for regeneration of any damage to the tendons and ligaments" as a flat statement, with no qualification about the state of the evidence, misleads viewers who will hear that as established medical fact. It isn't. The jump from rat Achilles tendons to a human shoulder injury is not a small one.
The injection technique shown looks reasonable for subcutaneous administration, though injecting near the injury site versus systemically produces different tissue concentration profiles, and that nuance affects how you interpret both the research and the personal experience claim. Daily injections for weeks also raises questions about desensitization and long-term safety signals that simply haven't been studied in humans.
- Correct: BPC-157 has preclinical evidence for tendon and ligament healing mechanisms
- Correct: subcutaneous injection is the commonly used route in research protocols
- Overstated: calling it "great" for regeneration implies human clinical validation that doesn't exist yet
- Missing: no mention of regulatory status, sourcing risk, or the absence of human trials
What should you actually know?
BPC-157 is not FDA-approved, is not legally available as a human drug in the US, and cannot currently be prescribed through standard medical channels. Peptides sold online for injection are not subject to pharmaceutical-grade manufacturing standards, which creates real contamination and dosing accuracy risks. That's not a hypothetical concern. It's a documented problem with unregulated peptide markets.
The preclinical science is legitimately interesting, which is why researchers are still pursuing it. Sikiric's group has published consistently for over two decades. But "interesting preclinical signal" and "clinically validated treatment" are not the same thing, and conflating them in a 70,000-view TikTok has consequences for people who go source this stuff without medical supervision.
If you're recovering from a real musculoskeletal injury and you're curious about peptide therapy, the conversation belongs with a licensed provider who can assess your injury, review your full health picture, and discuss what evidence actually exists. Self-injection of unregulated peptides based on TikTok recovery stories is a meaningful health risk, regardless of what the rat data says.